Novel Ophthalmic Drug Delivery


Anatomy and physiology of the eye protect it from damage. It therefore minimizes the transport of medication by traditional dosage forms to the eye, and the therapeutic concentration of drugs may not be maintained for long periods of time. Ocular drug delivery systems allowed for long-term treatment of ocular infections by delivering medication directly to the anterior segment of the eye. For the treatment of chronic vitreoretinal diseases, different biodegradable or non-biodegradable polymer implants have been widely investigated. Developing ocular drug delivery systems that provide controlled release of medication can reduce the dosing frequency for chronic diseases.


  • Nanoparticles
  • Drug embedded contact lenses
  • Iontophorosis

Related Conference of Novel Ophthalmic Drug Delivery

November 19-20, 2025

16th European Conference on Surgery & Cosmetology

Barcelona, Spain
December 04-05, 2025

8th Annual Summit on Surgery and Transplantation

Paris, France
January 26-27, 2026

3rd Global Summit on Geriatrics & Aging

Paris, France
May 14-15, 2026

6th World Congress on Surgery

London, UK

Novel Ophthalmic Drug Delivery Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in